Skip to main content
. 2022 Jul 23;17:50. doi: 10.1186/s13012-022-01223-6

Table 3.

Outcome measures and type of impact reported in included studies

Target group Outcome measures Type of impact reported in included studies (n, %) References Total studies (n, %)
Positive (all reported outcomes improved) Mixed (some reported outcomes improved) No change (no outcomes improved)
Patient/family Patient outcomes (e.g., reduced cholesterol) 3, 2.5% [57, 66, 99] --- --- 3, 2.5%
Behavior (e.g., medication adherence) 2, 1.7% [75, 102] --- 1, 0.8% [69] 3, 2.5%
Multiple outcomes 1, 0.8% [147] 1, 0.8% [130] 1, 0.8% [116] 3, 2.5%
Healthcare professional Knowledge, attitudes, beliefs 3, 2.5% [81, 126, 137] 1, 0.8% [145] 4, 3.4%
Behavior (e.g., medication prescribing) 35, 29.7% [42, 46, 4851, 54, 55, 59, 63, 71, 80, 82, 100, 103, 108110, 112, 113, 115, 119, 125, 127, 128, 132, 133, 136, 138, 140, 144, 146, 153, 154, 157] 13, 11% [45, 53, 77, 79, 86, 94, 97, 105, 107, 124, 129, 134, 150] 12, 10.2% [47, 58, 65, 67, 9193, 96, 101, 114, 118, 151] 60, 50.8%
Institutional/health system outcomes (e.g., reduced mortality or length of hospital stay) --- --- 1, 0.8% [84] 1, 0.8%
Multiple outcomes 12, 10.2% [56, 61, 62, 73, 74, 117, 121, 135, 139, 148, 149, 159] 2, 1.7% [44, 52] 1, 0.8% [88] 15, 12.7%
Both patient/family and healthcare professionals Multiple outcomes 10, 8.5% [76, 78, 83, 87, 120, 122, 131, 141, 142, 158] 14, 11.9% [43, 60, 64, 68, 70, 72, 85, 90, 98, 104, 111, 152, 155, 156] 5, 4.2% [89, 95, 106, 123, 143] 29, 24.6%
Total 66, 55.9% 31, 26.3% 21, 17.8% 118, 100%